Masaharu Ishikura None;
Yuki Muraoka Bayer Yakuhin,Novartis Pharma,Alcon Japan, Code F (Financial Support), Canon,Santen Pharmaceutical,Senju Pharmaceutical,Bayer Yakuhin,Novartis Pharma,AMO Japan,HOYA,Johnson & Johnson K.K., Code R (Recipient);
Naomi Nishigori None;
Takahiro Kogo None;
Shogo Numa Senju Pharmaceutical,Kowa Pharmaceutical,Santen Pharmaceutical, Code R (Recipient);
Kenji Ishihara None;
Masayuki Hata Novartis Pharma, Code F (Financial Support), Kyoto Drug Discovery & Development, Code P (Patent), Senju Pharmaceutical, Code R (Recipient);
Akitaka Tsujikawa Senju Pharmaceutical,Bayer Yakuhin,Novartis Pharma,HOYA,Ellex,Allegan Japan,Eisai,Daiich-Sankyo,Chugai Pharmaceutical,MSD, Code C (Consultant/Contractor), Canon,Findex,Santen Pharmaceutical,Kowa Pharmaceutical,Pfizer,AMO Japan,Senju Pharmaceutical,Wakamoto Pharmaceutical,Alcon Japan,Novartis Pharma,Otsuka Pharmaceutical,Bayer Yakuhin,Nitten Pharmaceutical, Code F (Financial Support), Bayer Yakuhin,Senju Pharmaceutical,Novartis Pharma,Santen Pharmaceutical,Alcon Pharma,Alcon Japan,AbbVie GK,AMO Japan,Kowa Pharmaceutical,Canon,Otsuka Pharmaceutical,Wakamoto Pharmaceutical, Code R (Recipient)